Navigation Links
Study Finds Benefits With Drug-Coated Stents
Date:10/3/2007

Better outcomes for high-risk patients

WEDNESDAY, Oct. 3 (HealthDay News) -- Drug-coated stents offered a clear advantage over the bare-metal kind for high-risk patients with blocked coronary arteries, a large Canadian study found.

The rate of restenosis -- having the artery become blocked again after stent implant -- was "significantly lower" over the following two years for those getting drug-coated stents, 7.4 percent versus 10.7 percent. The three-year death rate was 5.5 percent in the coated-stent group, compared to 7.8 percent in the bare-metal group.

"We found the results in low-risk patients were almost identical [between the two types of stents], so we would reserve coated stents for high-risk cases," said study lead author Dr. Jack V. Tu, a senior scientist at the Institute for Clinical Evaluative Sciences in Toronto.

The study findings also provide some comfort about worries that a high rate of restenosis increases the risk of heart attacks in those getting coated stents. The two-year heart attack rate was similar in the two groups, 5.2 percent for bare-metal stents and 5.7 percent for coated stents.

"These were traditional heart attacks rather than being caused by restenosis, so it provides a lot of reassurance," Tu said.

The findings are published in the Oct. 4 issue of the New England Journal of Medicine.

The dominant drug-eluting stent used in the trial was the Taxus, coated with the drug paclitaxel and marketed by Boston Scientific, Tu said. It was used in 80 of those getting a coated stent, with about 17 percent getting the Cypher, which is coated with sirolimus and marketed by Cordis.

Recent studies have found the risk of restenosis is lower with the Cypher stent. Tu said his group has not yet looked for a product-to-product comparison.

The study defined high risk as the presence of two of three risk factors for restenosis -- diabetes, having smaller blood vessels and having very long blockages.

Use of a bare-metal stent versus a drug-coated stent thus depends on a recipient's risk profile, Tu said. "Unless I were a high-risk patient with two or three risk factors, I would be better off with a bare-metal stent," he said. I would reserve the coated stent for high-risk patients.

Dr. Steven Nissen, chairman of cardiovascular medicine at the Cleveland Clinic, said the findings should be interpreted with care, because the study was "observational," looking at what was done in medical practice without the strict effort to balance all factors done in a controlled trial.

"Observational data has significant limitations, particularly that the patients who received bare-metal stents rather than coated stents may have been different," Nissen said. "Observational studies try to account for those differences by matching patients carefully, but matching is an imperfect science."

The "big surprise" of the study was the reduction of the death rate with drug-eluting stents, Nissen said. "But the authors appropriately caution that the finding needs confirmation by randomized clinical trials," he said.

"In my view, we've learned all we can from observational trials," Nissen added. "We need a good long-term controlled trial" of stents.

However, Dr. Kirk Garratt, clinical director of interventional cardiovascular research at Lenox Hill Hospital in New York City, said the Canadian trial was no ordinary observational study.

"The best thing about this paper is the technique they used for matching bare-metal stent patients with drug-coated stent patients," Garratt said. "It was easy for me to figure out quickly and easily the impact of having put a drug-coated stent into a patient. It was linked to an important improvement in how patients do over a long period of time."

One reason the coated stents performed so well is that Canada's health-care system automatically provides the clot-preventing drug Plavix, plus aspirin, for all stent recipients. Those drugs are recommended for American recipients, and the federal government recently began to pay for them, Garratt said.

"That is reason to hope that the U.S. population will see these benefits in the next few years," he said.

More information

You can learn why and how stents are used from the U.S. National Heart, Lung, and Blood Institute.



SOURCES: Jack V. Tu, M.D., senior scientist, Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada; Steven Nissen, M.D., chairman of cardiovascular medicine, Cleveland Clinic; Kirk Garratt, M.D., clinical director of interventional cardiovascular research, Lenox Hill Hospital, New York City; Oct. 4, 2007, New England Journal of Medicine


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Rural Canadians travel far for specialists: study
2. A new study surpasses Gene Therapy Hurdle
3. Tomato Sauce reduces Cancer Risk- Study
4. A question on study of Adult Stem Cell
5. Study on obesity and heart failure
6. National Lung Study in the process
7. Marijuana gateway theory strengthened by study of twins
8. Old theory of adaptation confirmed by new study
9. Study casts doubt on keyboard ills
10. Gene study links endometriosis, infertility
11. Study reveals how stress can make you sick
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest ... . , Millions of individuals in the United States and Canada wear eyeglasses. Once ... to both correct vision and make a fashion statement. Even celebrities use glasses as ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever ... Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation ... as home to some of the world’s leading providers of cereal and other breakfast ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , Belgium , June ... MKT: VNRX), today announced the appointment of Dr. ... of Directors as a Non-Executive Director, effective June ... Company,s Audit, Compensation and Nominations and Governance Committees.  ... Dr. Futcher will provide independent expertise and strategic ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
Breaking Medicine Technology: